Access 2,500+ research biosimilar antibodies produced using the same variable-region sequences as approved therapeutic antibodies. Covering targets across oncology (HER2, EGFR, PD-1/PD-L1, CD20), autoimmune disease (TNF-α, IL-6R, IL-17A), and ophthalmology (VEGF). Designed for mechanism-of-action studies, ADA/PK assay development, and preclinical pharmacology at research-grade pricing. All products are designated Research Use Only (RUO) — not intended for diagnostic or therapeutic procedures. RUO
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-lambda
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG2-lambda
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-lambda